Manager QA, EU Qualified Person Cell Therapy

At Bristol Myers Squibb, our employees often ask, 'Who are you working for?' - a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits.

This is work that transforms the lives of patients, and the careers of those who do it.

The Manager EU QP supports in the implementation and execution of the Quality Assurance function and Quality Management System of BMS Netherlands Operations BV which will ensure product quality and compliance with all regulatory and corporate requirements for Investigational and Commercial ATMP (Gene Therapy) Products within Europe and Rest of World Markets as applicable. This position acts in its primary role as Qualified person for investigational and commercial Cell Therapy products within EU/EEA and Rest of World Markets as applicable.

These duties and responsibilities are executed in accordance with the requirements of the BMS Netherlands Operations BV license and the Professional Code of Conduct.

• Act as Qualified Person as per requirements of BMS Netherlands Operations BV licences and execute functions in accordance with Professional Code of Conduct
• Fulfil Qualified Person duties as defined in article 51 of 2001/83/EC, Annex 16, Annex 13 and the ATMP guidelines of Volume 4 of the EU GMP guidelines
• Interpret international, regional, and local regulations and apply those regulations within the GMP/GDP environment and the batch disposition process in the EU/EEA and Rest of World Markets as applicable.
• Perform the verification of QP certification of imported Advanced Therapy Medicinal Products (ATMPs) Investigational Medicinal products (IMP) into the United Kingdom in accordance with MHRA guidelines "Importing Investigational Medicinal Products (IMP) from countries on a list to Great Britain", as assigned
• Build up a deep knowledge of the cell therapy-based processes, technology and the specific treatments which are intended to be commercialized
• Interact with global, site, and vendor oversight Quality and Supply Chain functions to ensure a compliant, efficient, and timely batch disposition for cell therapies
• Participate in GMP- or GDP-related health authority inspections at Celgene Distribution BV, BMS Netherlands Operations BV and other BMS entities as required, respond to any noted observations, and ensure implementation of corrective actions
• Manage quality and compliance risks by conducting risk assessments and ensuring risk mitigation actions are taken
• Develop and maintain a release process which takes into account the specifics of autologous cell therapy treatments with staged release, treatment of OOS results and related risk assessments
• Conduct final review and approval of non-routine quality investigations related to batch deviations, batch disposition, and other quality systems for assigned products as required
• Identify and recommend product and process quality improvements
• Support BMS Netherlands Operations BV for implementing and maintaining and continuously improving the quality management system
• Author and/or revise procedures, work instructions, and Standards, as required
• Maintain compliance with personal training requirements
• Draft or review, negotiate with contractors, and recommend approval for Quality Agreements
• Participate in GMP audits of suppliers, and service providers as required

The Manager QA, EU QP Cell Therapy reports administratively and functionally to the Director, Disposition…